Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
Sage Therapeutics rejects Biogen deal offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast bids on ...
Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / January 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...
BioSpace16h
You Can’t Buy Us: Biotechs Turn to Courts to Fight Off Potential Buyers
Biogen’s effort to buy Sage against the board’s wishes and a long-time effort by investor Alcorn to scuttle Aurion’s IPO ...
Japan In The Spotlight; Blockchain In AI's Shadow
As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.
Biogen, Eisai Alzheimer’s drug review delayed in EU
Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) are expected to face another delay in launching their new Alzheimer's drug, lecanemab, in the EU after the European Commission on Friday asked the region's ...
The Sheridan Press2h
Artists are everywhere: SAGE photography show celebrates Sheridan artists
In its 10th year, SAGE opened its "My Hometown" photography show to anyone with a phone camera, stipulating any photo submitted needed to be taken and edited by phone.
Indiatimes14h
Gland Pharma Share Price
Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 24,818.20 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...
Indiatimes14h
Piramal Pharma Share Price
Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...